Apply on Employer Site

Precision Medicine Group · 9 hours ago

Medical Writing Intern (PharmD)

United States

Internship

Remote

Intern

$30/hr - $30/hr

Start in 2026 Winter

Precision Medicine Group is offering an immersive internship program for PharmD candidates eager to gain hands-on experience in pharmaceutical marketing. As a Medical Writing Intern, you will work with the Market Access team to develop content for various deliverables and enhance your skills in evaluating scientific literature and coordinating references.

BiotechnologyHealth Care

Responsibilities

Work closely with the Market Access team to gain exposure to the principles of medical writing

Develop content for a range of deliverables targeting access decision makers

Build essential skills in evaluating scientific literature, coordinating references, and verifying the accuracy of cited information used in pharmaceutical marketing materials and medical, legal, and regulatory submissions

Qualification

PharmDScientific literature evaluationWritten communicationMicrosoft OfficeAdobe AcrobatAMA style guideVerbal communicationAttention to detailTime management

Required

PharmD candidates expected to graduate by June 2026

Impeccable written and verbal communications skills

Expertise in gathering, evaluating, and summarizing scientific literature

Proficiency of Microsoft Office (PowerPoint, Word, Excel) and Adobe Acrobat

Preferred

Working knowledge of AMA style guide

Prior experience in areas such: Medical and Drug Information

Prior experience in areas such: Medical Affairs

Prior experience in areas such: Regulatory Affairs

Prior experience in areas such: New Product Commercialization

Prior experience in areas such: Promotional Agencies

Working knowledge of managed markets, healthcare systems, and healthcare delivery

Involvement in professional organizations such as Academy of Managed Care Pharmacy (AMCP) and Industry Pharmacists Organization (IPhO)

Company

Precision Medicine Group

Glassdoor3.6

We founded Precision Medicine Group in 2012 because we believed there was a transformational opportunity to improve the process of bringing new drugs to market.

Founded in 2012